First Manhattan’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

First Manhattan’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-73,853	Closed	-$1.86M	–	745
2025 Q3	$1.86M	Sell	73,853 -1,803	-2%	-$45.3K	﹤0.01%	348
2025 Q2	$1.91M	Buy	75,656 +477	+0.6%	+$12K	0.01%	330
2025 Q1	$1.89M	Buy	75,179 +32,727	+77%	+$822K	0.01%	314
2024 Q4	$1.06M	Buy	42,452 +19,512	+85%	+$489K	﹤0.01%	388
2024 Q3	$576K	Buy	+22,940	New	+$573K	﹤0.01%	459
2024 Q2	–	Sell	-1,790	Closed	-$44.4K	–	949
2024 Q1	$44.4K	Buy	1,790 +315	+21%	+$7.8K	﹤0.01%	914
2023 Q4	$36.5K	Buy	+1,475	New	+$36.1K	﹤0.01%	930

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Manhattan's IBDQ Position: Q4 2025 in Review

First Manhattan sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 73,853 shares — an estimated $1.86M sold.

First Manhattan first reported a position in IBDQ in Q4 2023 and held it in 7 quarters. The position peaked at $1.91M in Q2 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

First Manhattan reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
First Manhattan sold 73,853 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $1.86M.
First Manhattan first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2023 and held it in 7 quarters.
First Manhattan's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $1.91M in Q2 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on First Manhattan's 13F filing for Q4 2025, filed 17 Feb 2026.